Skip to main content
Download PDF

Correction: Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a mendelian randomization analysis

Alzheimer's Research & Therapy volume 16, Article number: 276 (2024) Cite this article

The Original Article was published on 16 October 2024

Correction: Alz Res Therapy 16, 228 (2024)

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13195-024-01594-6

Following publication of the original article [1], an important textual error was noticed and corrected in the fourth paragraph of Background section.

The current wording erroneously states that CETP inhibitors decreases Apo-E concentration:

However, all CETP inhibitors, including the novel CETP-inhibitor obicetrapib, lowers plasma concentrations of apolipoprotein-E (Apo-E) [4] which is a known risk factor for dementia, in particular for Alzheimer’s disease (AD).

Whereas the cited reference [4] actually shows an increasing effect. The correct wording should read:

However, all CETP inhibitors, including the novel CETP-inhibitor obicetrapib, increase plasma concentrations of apolipoprotein-E (Apo-E) [4], which is associated with decreased risk of dementia, in particular for Alzheimer’s disease (AD).

The original article [1] has been updated.

References

  1. Schmidt AF, Davidson MH, Ditmarsch M, et al. Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a mendelian randomization analysis. Alz Res Therapy. 2024;16:228. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13195-024-01594-6.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Cardiovascular Science, Faculty of Population Health, University College London, 69-75 Chenies Mews, London, WC1E 6HX, UK

    Amand F. Schmidt & Chris Finan

  2. UCL British Heart Foundation Research Accelerator, 69-75 Chenies Mews, London, WC1E 6HX, UK

    Amand F. Schmidt & Chris Finan

  3. Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam UMC, locatie AMC Postbus 22660, Amsterdam Zuidoost, 1100 DD, The Netherlands

    Amand F. Schmidt

  4. Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands

    Amand F. Schmidt & Chris Finan

  5. Pritzker School of Medicine, University of Chicago, 5801 S Ellis Ave, Chicago, IL, 60637, USA

    Michael H. Davidson

  6. NewAmsterdam Pharma B.V, Gooimeer 2-35, Naarden, 1411 DC, Netherlands

    Michael H. Davidson, Marc Ditmarsch & John J. Kastelein

  7. Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam UMC, locatie AMC Postbus 22660, Amsterdam Zuidoost, 1100 DD, The Netherlands

    John J. Kastelein

Authors
  1. Amand F. Schmidt
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Michael H. Davidson
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Marc Ditmarsch
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. John J. Kastelein
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Chris Finan
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Amand F. Schmidt.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13195-024-01594-6.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schmidt, A.F., Davidson, M.H., Ditmarsch, M. et al. Correction: Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a mendelian randomization analysis. Alz Res Therapy 16, 276 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13195-024-01639-w

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13195-024-01639-w

Alzheimer's Research & Therapy

ISSN: 1758-9193